A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- OBSERVATIONAL
- Evidence population
- Human clinical study registration
- Participants
- 300
- Population
- ALL · 60 Years
- Duration
- 2026-09-01 to 2030-09-30
- Intervention
- Comparator
- Not reported
- Outcomes measured
- Net Clinical Benefit at Week 52 — 52 Weeks; Steroid-Free Clinical Remission at Week 26 — 26 Weeks; Steroid-Free Clinical Remission at Week 52 — 52 weeks; Advanced Therapy Persistence at Week 52 — 52 weeks; Incidence of Serious Infection — From Baseline Through Week 52; Incidence of IBD-Related Hospitalization — From Baseline Through Week 52; Change From Baseline in Inflammatory Bowel Disease Frailty Score at Week 26 — Baseline and Week 26; Change From Baseline in Inflammatory Bowel Disease Frailty Score at Week 52 — Baseline and Week 52; Change From Baseline in Clinical Frailty Scale Score at Week 52 — Baseline and Week 52
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Immune ageing · 100%Title contains controlled term: immune aging. Abstract contains controlled term: immune aging. Source terminology contains: immunosenescence. Title supplies longevity context: aging, older adult. Study type is explicitly identified as OBSERVATIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.